The DOI matches its Crossref record; 274 of the 274 references it cites were found in a registry or an index.
The mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group
Open accessAbstract
The simultaneous intake of food and drugs can have a strong impact on drug release, absorption, distribution, metabolism and/or elimination and consequently, on the efficacy and safety of pharmacotherapy. As such, food-drug interactions are one of the main challenges in oral drug administration. Whereas pharmacokinetic (PK) food-drug interactions can have a variety of causes, pharmacodynamic (PD) food-drug interactions occur due to specific pharmacological interactions between a drug and particular drinks or food. In recent years, extensive efforts were made to elucidate the mechanisms that drive pharmacokinetic food-drug interactions. Their occurrence depends mainly on the properties of the drug substance, the formulation and a multitude of physiological factors. Every intake of food or drink changes the physiological conditions in the human gastrointestinal tract. Therefore, a precise understanding of how different foods and drinks affect the processes of drug absorption, distribution, metabolism and/or elimination as well as formulation performance is important in order to be able to predict and avoid such interactions. Furthermore, it must be considered that beverages such as milk, grapefruit juice and alcohol can also lead to specific food-drug interactions. In this regard, the growing use of food supplements and functional food requires urgent attention in oral pharmacotherapy. Recently, a new consortium in Understanding Gastrointestinal Absorption-related Processes (UNGAP) was established through COST, a funding organisation of the European Union supporting translational research across Europe. In this review of the UNGAP Working group "Food-Drug Interface", the different mechanisms that can lead to pharmacokinetic food-drug interactions are discussed and summarised from different expert perspectives.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diet rapidly and reproducibly alters the human gut microbiome
David, L. A., Maurice, C. F., Carmody, R. N., Gootenberg, D. B., Button, J. E., Wolfe, B. E., Ling, A. V., Devlin, A. S., Varma, Y., Fischbach, M. A., et al. (2014) · Nature · doi:10.1038/nature12820 · Cited by 10,100
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Lipids and Lipid-Based Formulations: Optimizing the Oral Delivery of Lipophilic Drugs
Porter, C. J. H., Trevaskis, N. L., & Charman, W. N. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2197 · Cited by 1,824
Self-citationWalstra, P., Walstra, P., Wouters, J. T. M., & Geurts, T. J. (2005) · doi:10.1201/9781420028010 · Cited by 1,788
Strategies to Address Low Drug Solubility in Discovery and Development
Williams, H. D., Trevaskis, N. L., Charman, S. A., Shanker, R. M., Charman, W. N., Pouton, C. W., & Porter, C. J. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005660 · Cited by 1,570
Self-citationLeslie, E. M., Deeley, R. G., & Cole, S. P. C. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.10.012 · Cited by 1,406
(1995) · Elsevier eBooks · doi:10.1016/b978-0-12-384430-9.x5000-8 · Cited by 1,147
Scientific Concepts of Functional Foods in Europe Consensus Document
(1999) · British Journal of Nutrition · doi:10.1017/s0007114599000471 · Cited by 1,131
Dresser, G. K., Spence, J. D., & Bailey, D. G. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200038010-00003 · Cited by 908
McEvoy, G. K. (1994) · Oncology Issues · doi:10.1080/10463356.1994.11904493 · Cited by 888
THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
Paine, M. F., Hart, H. L., Ludington, S. S., Haining, R. L., Rettie, A. E., & Zeldin, D. C. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.008672 · Cited by 870
The superfamily of organic anion transporting polypeptides
Hagenbuch, B., & Meier, P. J. (2003) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(02)00633-8 · Cited by 861
Transit of pharmaceutical dosage forms through the small intestine.
Davis, S. S., Hardy, J. G., & Fara, J. W. (1986) · Gut · doi:10.1136/gut.27.8.886 · Cited by 853
Exploiting non-covalent π interactions for catalyst design
Neel, A. J., Hilton, M. J., Sigman, M. S., & Toste, F. D. (2017) · Nature · doi:10.1038/nature21701 · Cited by 830
Pharmaco-metabonomic phenotyping and personalized drug treatment
Andrew Clayton, T., Lindon, J. C., Cloarec, O., Antti, H., Charuel, C., Hanton, G., Provost, J.-P., Le Net, J.-L., Baker, D., Walley, R. J., et al. (2006) · Nature · doi:10.1038/nature04648 · Cited by 824
Grapefruit juice–drug interactions
Bailey, D. G., Malcolm, J., Arnold, O., & David Spence, J. (1998) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.1998.00764.x · Cited by 740
Hasler, C. M. (2002) · The Journal of Nutrition · doi:10.1093/jn/132.12.3772 · Cited by 698
Fletcher, C. V., Staskus, K., Wietgrefe, S. W., Rothenberger, M., Reilly, C., Chipman, J. G., Beilman, G. J., Khoruts, A., Thorkelson, A., Schmidt, T. E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318249111 · Cited by 664
Gut microbiome interactions with drug metabolism, efficacy, and toxicity
Wilson, I. D., & Nicholson, J. K. (2017) · Translational Research · doi:10.1016/j.trsl.2016.08.002 · Cited by 656
From Sewer to Saviour—Targeting the Lymphatic System to Promote Drug Exposure and Activity
Trevaskis, N. L., Kaminskas, L. M., & Porter, C. J. H. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4608 · Cited by 654
Self-citationLown, K. S., Bailey, D. G., Fontana, R. J., Janardan, S. K., Adair, C. H., Fortlage, L. A., Brown, M. B., Guo, W., & Watkins, P. B. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119439 · Cited by 624
The gastrointestinal microbiota as a site for the biotransformation of drugs
Sousa, T., Paterson, R., Moore, V., Carlsson, A., Abrahamsson, B., & Basit, A. W. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.07.009 · Cited by 618
Self-citationDresser, G. K., Bailey, D. G., Leake, B. F., Schwarz, U. I., Dawson, P. A., Freeman, D. J., & Kim, R. B. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.121152 · Cited by 606
Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging
SCHILLER, C., FRÖHLICH, C. ‐., GIESSMANN, T., SIEGMUND, W., MÖNNIKES, H., HOSTEN, N., & WEITSCHIES, W. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02683.x · Cited by 596
Modulation of Liposomal Membrane Fluidity by Flavonoids and Isoflavonoids
Arora, A., Byrem, T. M., Nair, M. G., & Strasburg, G. M. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1525 · Cited by 594
Hilgendorf, C., Ahlin, G., Seithel, A., Artursson, P., Ungell, A.-L., & Karlsson, J. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.107.014902 · Cited by 583
Fleisher, D., Li, C., Zhou, Y., Pao, L., & Karim, A. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936030-00004 · Cited by 506
Marciani, L., Gowland, P. A., Spiller, R. C., Manoj, P., Moore, R. J., Young, P., & Fillery-Travis, A. J. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.6.g1227 · Cited by 502
Self-citationDuffy, E. M., & Jorgensen, W. L. (2000) · Journal of the American Chemical Society · doi:10.1021/ja993663t · Cited by 498
Mudie, D. M., Murray, K., Hoad, C. L., Pritchard, S. E., Garnett, M. C., Amidon, G. L., Gowland, P. A., Spiller, R. C., Amidon, G. E., & Marciani, L. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500210c · Cited by 486
Self-citationKoziolek, M., Grimm, M., Becker, D., Iordanov, V., Zou, H., Shimizu, J., Wanke, C., Garbacz, G., & Weitschies, W. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24274 · Cited by 464
Self-citationAlbumin–drug interaction and its clinical implication
Yamasaki, K., Chuang, V. T. G., Maruyama, T., & Otagiri, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.05.005 · Cited by 464
Geirnaert, A., Calatayud, M., Grootaert, C., Laukens, D., Devriese, S., Smagghe, G., De Vos, M., Boon, N., & Van de Wiele, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-11734-8 · Cited by 451
Lipid-Based Delivery Systems and Intestinal Lymphatic Drug Transport: A Mechanistic Update
Trevaskis, N. L., Charman, W. N., & Porter, C. J. H. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.09.007 · Cited by 442
Self-citationCustodio, J. M., Wu, C.-Y., & Benet, L. Z. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.08.043 · Cited by 434
The effect of garlic supplements on the pharmacokinetics of saquinavir
Piscitelli, S. C., Burstein, A. H., Welden, N., Gallicano, K. D., & Falloon, J. (2002) · Clinical Infectious Diseases · doi:10.1086/324351 · Cited by 431
Shitara, Y., Maeda, K., Ikejiri, K., Yoshida, K., Horie, T., & Sugiyama, Y. (2013) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.1823 · Cited by 418
Kobayashi, D., Nozawa, T., Imai, K., Nezu, J.-I., Tsuji, A., & Tamai, I. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.051300 · Cited by 416
Intestinal Drug Transporter Expression and the Impact of Grapefruit Juice in Humans
Glaeser, H., Bailey, D. G., Dresser, G. K., Gregor, J. C., Schwarz, U. I., McGrath, J. S., Jolicoeur, E., Lee, W., Leake, B. F., Tirona, R. G., et al. (2007) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100056 · Cited by 407
Functional components and medicinal properties of food: a review
Abuajah, C. I., Ogbonna, A. C., & Osuji, C. M. (2015) · Journal of Food Science and Technology · doi:10.1007/s13197-014-1396-5 · Cited by 404
Effect of St John's Wort on Drug Metabolism by Induction of Cytochrome P450 3A4 Enzyme
Markowitz, J. S. (2003) · JAMA · doi:10.1001/jama.290.11.1500 · Cited by 403
Huang, S., Strong, J. M., Zhang, L., Reynolds, K. S., Nallani, S., Temple, R., Abraham, S., Habet, S. A., Baweja, R. K., Burckart, G. J., et al. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270007312153 · Cited by 396
St John's wort (Hypericum perforatum): drug interactions and clinical outcomes
Henderson, L., Yue, Q. Y., Bergquist, C., Gerden, B., & Arlett, P. (2002) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2002.01683.x · Cited by 380
Nutraceuticals and Functional Foods: The Foods for the Future World
Gul, K., Singh, A. K., & Jabeen, R. (2016) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.903384 · Cited by 368
HUMAN ALPHA-1-GLYCOPROTEIN AND ITS INTERACTIONS WITH DRUGS†,‡
Israili, Z. H., & Dayton, P. G. (2001) · Drug Metabolism Reviews · doi:10.1081/dmr-100104402 · Cited by 367
Effects of Food on Clinical Pharmacokinetics
Singh, B. N. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199937030-00003 · Cited by 364
Expression and function of efflux drug transporters in the intestine
Takano, M., Yumoto, R., & Murakami, T. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.005 · Cited by 356
Wu, C.-Y., Benet, L. Z., Hebert, M. F., Gupta, S. K., Rowland, M., Gomez, D. Y., & Wacher, V. J. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90168-x · Cited by 356
Murray, K., Wilkinson-Smith, V., Hoad, C., Costigan, C., Cox, E., Lam, C., Marciani, L., Gowland, P., & Spiller, R. C. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.386 · Cited by 355
Self-citationThe migrating motor complex: control mechanisms and its role in health and disease
Deloose, E., Janssen, P., Depoortere, I., & Tack, J. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.57 · Cited by 352
Functional Characterization of pH-Sensitive Organic Anion Transporting Polypeptide OATP-B in Human
Nozawa, T., Imai, K., Nezu, J.-I., Tsuji, A., & Tamai, I. (2004) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060194 · Cited by 351
Janssen, P., Vanden Berghe, P., Verschueren, S., Lehmann, A., Depoortere, I., & Tack, J. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04609.x · Cited by 348
Drug Interactions with Grapefruit Juice
Ameer, B., & Weintraub, R. A. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199733020-00003 · Cited by 348
Cytochrome P450 phenotypic ratios for predicting herb‐drug interactions in humans
Gurley, B. J., Gardner, S. F., Hubbard, M. A., Williams, D. K., Gentry, W. B., Cui, Y., & Ang, C. Y. W. (2002) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2002.126913 · Cited by 343
Garlic and Onions: Their Cancer Prevention Properties
Nicastro, H. L., Ross, S. A., & Milner, J. A. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0172 · Cited by 336
Liver Abscess Due to a Lactobacillus rhamnosus Strain Indistinguishable from L. rhamnosus Strain GG
Rautio, M., Jousimies‐Somer, H., Kauma, H., Pietarinen, I., Saxelin, M., Tynkkynen, S., & Koskela, M. (1999) · Clinical Infectious Diseases · doi:10.1086/514766 · Cited by 327
Smith, D. E., Clémençon, B., & Hediger, M. A. (2013) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.11.003 · Cited by 326
Multidrug Resistance Proteins (MRPs, ABCCs): Importance for Pathophysiology and Drug Therapy
Keppler, D. (2011) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-14541-4_8 · Cited by 318
Schmidt, L. E., & Dalhoff, K. (2002) · Drugs · doi:10.2165/00003495-200262100-00005 · Cited by 316
Nakanishi, T., & Ross, D. D. (2012) · Chinese Journal of Cancer · doi:10.5732/cjc.011.10320 · Cited by 301
Caliph, S. M., Charman, W. N., & Porter, C. J. H. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200008)89:8<1073::aid-jps12>3.0.co;2-v · Cited by 292
Self-citationMarchetti, S., Mazzanti, R., Beijnen, J. H., & Schellens, J. H. M. (2007) · The Oncologist · doi:10.1634/theoncologist.12-8-927 · Cited by 284
Flavonoid–drug interactions: Effects of flavonoids on ABC transporters
Morris, M. E., & Zhang, S. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.12.003 · Cited by 273
Fenner, K., Troutman, M., Kempshall, S., Cook, J., Ware, J., Smith, D., & Lee, C. (2009) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2008.195 · Cited by 272
Jukic, M., Politeo, O., Maksimovic, M., Milos, M., & Milos, M. (2007) · Phytotherapy Research · doi:10.1002/ptr.2063 · Cited by 271
Wasan, K. M., Brocks, D. R., Lee, S. D., Sachs-Barrable, K., & Thornton, S. J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2353 · Cited by 269
Role of OATP Transporters in the Disposition of Drugs
Niemi, M. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.7.787 · Cited by 266
CYP induction-mediated drug interactions: in vitro assessment and clinical implications
Lin, J. H. (2006) · Pharmaceutical Research · doi:10.1007/s11095-006-0277-7 · Cited by 264
Prediction of drug–ABC-transporter interaction — Recent advances and future challenges
Montanari, F., & Ecker, G. F. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.03.001 · Cited by 257
Classification Analysis of P-Glycoprotein Substrate Specificity
Didziapetris, R., Japertas, P., Avdeef, A., & Petrauskas, A. (2003) · Journal of Drug Targeting · doi:10.1080/10611860310001648248 · Cited by 253
Pharmacokinetic Interactions of Drugs with St John’s Wort
Zhou, S., Chan, E., Pan, S.-Q., Huang, M., & Lee, E. J. D. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104042632 · Cited by 253
Dahan, A., & Altman, H. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601736 · Cited by 249
(2007) · Desk Reference of Clinical Pharmacology, Second Edition · doi:10.1201/9781420047448.ch5 · Cited by 247
Protein Damage by Reactive Electrophiles: Targets and Consequences
Liebler, D. C. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700235t · Cited by 237
Lymphatic transport of high-density lipoproteins and chylomicrons
Randolph, G. J., & Miller, N. E. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71610 · Cited by 233
Interactions with the Absorption of Tetracyclines
Neuvonen, P. J. (1976) · Drugs · doi:10.2165/00003495-197611010-00004 · Cited by 230
Human gastric emptying and colonic filling of solids characterized by a new method
Camilleri, M., Colemont, L. J., Phillips, S. F., Brown, M. L., Thomforde, G. M., Chapman, N., & Zinsmeister, A. R. (1989) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1989.257.2.g284 · Cited by 227
Bennet, S. M. P., Böhn, L., Störsrud, S., Liljebo, T., Collin, L., Lindfors, P., Törnblom, H., Öhman, L., & Simrén, M. (2018) · Gut · doi:10.1136/gutjnl-2016-313128 · Cited by 225
Swallowing dysfunction and dysphagia is an unrecognized challenge for oral drug therapy
Stegemann, S., Gosch, M., & Breitkreutz, J. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.04.022 · Cited by 222
Intestinal lymphatic vasculature: structure, mechanisms and functions
Bernier-Latmani, J., & Petrova, T. V. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.79 · Cited by 219
Marciani, L., Cox, E. F., Hoad, C. L., Pritchard, S., Totman, J. J., Foley, S., Mistry, A., Evans, S., Gowland, P. A., & Spiller, R. C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.10.055 · Cited by 218
Self-citationEstimating the Maximal Potential for Intestinal Lymphatic Transport of Lipophilic Drug Molecules
Charman, W. N. A., & Stella, V. J. (1986) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(86)90027-x · Cited by 217
Dietary Effects on Drug Metabolism and Transport
Harris, R. Z., Jang, G. R., & Tsunoda, S. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342130-00001 · Cited by 216
Tognolini, M., Barocelli, E., Ballabeni, V., Bruni, R., Bianchi, A., Chiavarini, M., & Impicciatore, M. (2006) · Life Sciences · doi:10.1016/j.lfs.2005.07.020 · Cited by 214
Gut Microbiota and Tacrolimus Dosing in Kidney Transplantation
Lee, J. R., Muthukumar, T., Dadhania, D., Taur, Y., Jenq, R. R., Toussaint, N. C., Ling, L., Pamer, E., & Suthanthiran, M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0122399 · Cited by 211
Gorski, J. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(03)00187-5 · Cited by 205
Interactions of Green Tea Catechins with Organic Anion-Transporting Polypeptides
Roth, M., Timmermann, B. N., & Hagenbuch, B. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.110.036640 · Cited by 201
Tsai, H.-H., Lin, H.-W., Simon Pickard, A., Tsai, H.-Y., & Mahady, G. B. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2012.03008.x · Cited by 197
Interactions between CYP3A4 and Dietary Polyphenols
Basheer, L., & Kerem, Z. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/854015 · Cited by 195
SILYBIN INACTIVATES CYTOCHROMES P450 3A4 AND 2C9 AND INHIBITS MAJOR HEPATIC GLUCURONOSYLTRANSFERASES
Sridar, C., Goosen, T. C., Kent, U. M., Williams, J. A., & Hollenberg, P. F. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.6.587 · Cited by 192
A stomach road or “Magenstrasse” for gastric emptying
Pal, A., Brasseur, J. G., & Abrahamsson, B. (2007) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2006.06.006 · Cited by 190
Mougey, E. B., Feng, H., Castro, M., Irvin, C. G., & Lima, J. J. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32831bd98c · Cited by 190
Dresser, G. K., Kim, R. B., & Bailey, D. G. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.10.005 · Cited by 186
Imanaga, J., Kotegawa, T., Imai, H., Tsutsumi, K., Yoshizato, T., Ohyama, T., Shirasaka, Y., Tamai, I., Tateishi, T., & Ohashi, K. (2011) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32834300cc · Cited by 181
Rodríguez‐Fragoso, L., Martínez‐Arismendi, J. L., Orozco‐Bustos, D., Reyes‐Esparza, J., Torres, E., & Burchiel, S. W. (2011) · Journal of Food Science · doi:10.1111/j.1750-3841.2011.02155.x · Cited by 179
The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism.
Holtbecker, N., Fromm, M. F., Kroemer, H. K., Ohnhaus, E. E., & Heidemann, H. (1996) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08415-6 · Cited by 178
Koziolek, M., Schneider, F., Grimm, M., Modeβ, C., Seekamp, A., Roustom, T., Siegmund, W., & Weitschies, W. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.022 · Cited by 176
Self-citationCurcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions
Adiwidjaja, J., McLachlan, A. J., & Boddy, A. V. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2017.1360279 · Cited by 173
Pharmacokinetic interactions of curcuminoids with conventional drugs: A review
Bahramsoltani, R., Rahimi, R., & Farzaei, M. H. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.07.022 · Cited by 171
Murphy, P. A., Kern, S. E., Stanczyk, F. Z., & Westhoff, C. L. (2005) · Contraception · doi:10.1016/j.contraception.2004.11.004 · Cited by 170
Mueller, E. A., Kovarik, J. M., van Bree, J. B., Grevel, J., Lücker, P. W., & Kutz, K. (1994) · Pharmaceutical Research · doi:10.1023/a:1018922517162 · Cited by 170
Koziolek, M., Grimm, M., Schneider, F., Jedamzik, P., Sager, M., Kühn, J.-P., Siegmund, W., & Weitschies, W. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.03.009 · Cited by 170
Self-citationGurley, B., Fifer, E., & Gardner, Z. (2012) · Planta Medica · doi:10.1055/s-0031-1298331 · Cited by 165
Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations
Kyrklund, C. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.111414 · Cited by 163
Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers
Ingels, F., Beck, B., Oth, M., & Augustijns, P. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.01.014 · Cited by 162
Self-citationGoetze, O., Steingoetter, A., Menne, D., van der Voort, I. R., Kwiatek, M. A., Boesiger, P., Weishaupt, D., Thumshirn, M., Fried, M., & Schwizer, W. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00498.2005 · Cited by 160
Current Methods for Predicting Human Food Effect
Lentz, K. A. (2008) · The AAPS Journal · doi:10.1208/s12248-008-9025-8 · Cited by 159
Lymphatic lipid transport: sewer or subway?
Dixon, J. B. (2010) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2010.04.003 · Cited by 155
Drug interaction potential of resveratrol
Detampel, P., Beck, M., Krähenbühl, S., & Huwyler, J. (2012) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.700715 · Cited by 154
On the Colonic Bacterial Metabolism of Azo-Bonded Prodrugsof 5-Aminosalicylic Acid
Sousa, T., Yadav, V., Zann, V., Borde, A., Abrahamsson, B., & Basit, A. W. (2014) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24103 · Cited by 151
Self-citationKhoo, S., Shackleford, D. M., Porter, C. J. H., Edwards, G. A., & Charman, W. N. (2003) · Pharmaceutical Research · doi:10.1023/a:1025718513246 · Cited by 150
Self-citationMechanisms underlying food–drug interactions: Inhibition of intestinal metabolism and transport
Won, C. S., Oberlies, N. H., & Paine, M. F. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.001 · Cited by 150
Structure – ADME relationship: still a long way to go?
Hou, T., & Wang, J. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.6.759 · Cited by 150
The Impact of the Gut Microbiota on Drug Metabolism and Clinical Outcome.
Enright, E. F., Gahan, C. G. M., Joyce, S. A., & Griffin, B. T. (2016) · PubMed · Cited by 149
Effects of Food on the Relative Bioavailability of Lapatinib in Cancer Patients
Koch, K. M., Reddy, N. J., Cohen, R. B., Lewis, N. L., Whitehead, B. P., Mackay, K., Stead, A. G., Beelen, A. P., & Lewis, L. D. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.3285 · Cited by 147
Murray, M. T. (2005) · Current Drug Metabolism · doi:10.2174/138920006774832569 · Cited by 145
Food, splanchnic blood flow, and bioavailability of drugs subject to first‐pass metabolism
McLean, A. J., McNamara, P. J., du Souich, P., Gibaldi, M., & Lalka, D. (1978) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt19782415 · Cited by 145
Droździk, M., Busch, D., Łapczuk-Romańska, J., Müller, J., Ostrowski, M., Kurzawski, M., & Oswald, S. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.967 · Cited by 144
Bioavailability of Tetracycline and Doxycycline in Fasted and Nonfasted Subjects
Welling, P. G., Koch, P. A., Lau, C. C., & Craig, W. A. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.11.3.462 · Cited by 142
TANNERGREN, C. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.12.012 · Cited by 138
Ryan, G. M., Kaminskas, L. M., & Porter, C. J. H. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.051 · Cited by 138
Self-citationWeitschies, W., Blume, H. H., & Mönnikes, H. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.07.007 · Cited by 138
Hubbard, G. P., Wolffram, S., de Vos, R. C. H., Bovy, A. G., Gibbins, J. M., & Lovegrove, J. A. (2006) · British Journal Of Nutrition · doi:10.1079/bjn20061831 · Cited by 137
Food and Symptom Generation in Functional Gastrointestinal Disorders: Physiological Aspects
Farré, R., & Tack, J. F. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.24 · Cited by 134
Transport of Peptidomimetic Drugs by the Intestinal Di/tri‐peptide Transporter, PepT1
Brodin, B., Nielsen, C. U., Steffansen, B., & Frøkjær, S. (2002) · Pharmacology & Toxicology · doi:10.1034/j.1600-0773.2002.900601.x · Cited by 133
Hens, B., Tsume, Y., Bermejo, M., Paixão, P. J. P. A., Koenigsknecht, M. J., Baker, J. R., Hasler, W. L., Lionberger, R. A., Fan, J., Dickens, J., et al. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00426 · Cited by 133
Self-citationEffect of Dietary Fatty Acids on Human Lipoprotein Metabolism: A Comprehensive Update
Ooi, E. M. M., Watts, G. F., Ng, T., & Barrett, P. H. R. (2015) · Nutrients · doi:10.3390/nu7064416 · Cited by 132
Ethnic and diet-related differences in the healthy infant microbiome
for the NutriGen Alliance, Stearns, J. C., Zulyniak, M. A., de Souza, R. J., Campbell, N., Fontes, M. E., Shaikh, M. R., Sears, M. R., Becker, A. B., Mandhane, P. J., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0421-5 · Cited by 132
Impact of the intragastric location of extended release tablets on food interactions
Weitschies, W., Wedemeyer, R., Kosch, O., Fach, K., Nagel, S., Söderlind, E., Trahms, L., Abrahamsson, B., & Mönnikes, H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.08.018 · Cited by 131
EFFECTS OF HERBAL EXTRACTS ON THE FUNCTION OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP-B
Fuchikami, H., Satoh, H., Tsujimoto, M., et al. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.007872 · Cited by 131
Mouly, S. J., Lloret‐Linares, C., Sellier, P., Sène, D., & Bergmann, J. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.09.038 · Cited by 131
Koziolek, M., Grimm, M. F., Garbacz, G., Kühn, J., & Weitschies, W. (2014) · Molecular Pharmaceutics · doi:10.1021/mp500022u · Cited by 130
Self-citationGrimm, M. F., Koziolek, M., Kühn, J., et al. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.03.002 · Cited by 128
Self-citationIntestinal drug efflux: formulation and food effects
Wagner, D., Spahn-Langguth, H., Hanafy, A., Koggel, A., & Langguth, P. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00183-1 · Cited by 127
The effect of gut microbiota on drug metabolism
Kang, M. J., Kim, H. G., Kim, J. S., Oh, D. G., Um, Y. J., Seo, C. S., Han, J. W., Cho, H. J., Kim, G. H., Jeong, T. C., et al. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.807798 · Cited by 125
Food for thought: formulating away the food effect – a PEARRL review
O’Shea, J. P., Holm, R., O’Driscoll, C. M., & Griffin, B. T. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12957 · Cited by 125
Yoshida, K. J., Maeda, K., & Sugiyama, Y. (2012) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011112-140309 · Cited by 123
Klein, S., Butler, J., Hempenstall, J., Reppas, C. I., & Dressman, J. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357023367 · Cited by 122
Self-citationFood, physiology and drug delivery
Varum, F., Hatton, G. B., & Basit, A. W. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.04.034 · Cited by 121
Self-citationLewis, S. J., & Freedman, A. R. (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00386.x · Cited by 121
Eldin, I. M. T., Ahmed, E. M., & Elwahab, H. M. A. (2010) · Environmental Health Insights · doi:10.4137/ehi.s5540 · Cited by 119
Drug transport via the intestinal peptide transporter PepT1
Brandsch, M. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.08.004 · Cited by 119
Interference of dairy products with the absorption of ciprofloxacin
Neuvonen, P. J., Kivistö, K. T., & Lehto, P. (1991) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1991.174 · Cited by 118
Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin
Ledergerber, B., Bettex, J.-D., Joos, B., Flepp, M., & Luthy, R. P. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.3.350 · Cited by 117
Zgair, A., Lee, J.-B., Wong, J. C., Taha, D. A., Aram, J., Virgilio, D. D., Mcarthur, J., Cheng, Y.-K., Hennig, I., Barrett, D., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15026-z · Cited by 117
Pharmacokinetic Interactions between Drugs and Botanical Dietary Supplements
Sprouse, A. A., & van Breemen, R. B. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.066902 · Cited by 116
Food effects on tablet disintegration
Abrahamsson, B., Albery, T., Eriksson, A., Gustafsson, I., & Sjöberg, M. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(04)00064-8 · Cited by 115
Galetin, A., Gertz, M., & Houston, J. B. (2010) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.25.28 · Cited by 113
Shackleford, D. M., Faassen, W. A., Houwing, N. S., Lass, H., Edwards, G. A., Porter, C. J. H., & Charman, W. N. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052522 · Cited by 113
Self-citationVarum, F., Merchant, H., & Basit, A. (2010) · International journal of pharmaceutics · doi:10.1016/j.ijpharm.2010.04.046 · Cited by 111
Self-citationBioavailability of Ampicillin and Amoxicillin in Fasted and Nonfasted Subjects
Welling, P. G., Huang, H., Koch, P. A., Craig, W. A., & Madsen, P. O. (1977) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600660423 · Cited by 111
Dai, X., Stanilka, J. M., Rowe, C. A., Esteves, E. A., Nieves, C., Spaiser, S. J., Christman, M. C., Langkamp‐Henken, B., & Percival, S. S. (2015) · Journal of the American College of Nutrition · doi:10.1080/07315724.2014.950391 · Cited by 111
Gurley, B. J. (2012) · Planta Medica · doi:10.1055/s-0031-1298273 · Cited by 110
Peters, S. A., Jones, C. R., Ungell, A.-L. B., & Hatley, O. J. D. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-015-0351-6 · Cited by 110
Koziolek, M., Garbacz, G., Neumann, M., & Weitschies, W. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300604u · Cited by 110
Self-citationPedersen, P. B., Vilmann, P., Bar‐Shalom, D., Müllertz, A., & Baldursdóttir, S. (2013) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2013.05.007 · Cited by 109
Effect of Alpha-1-Acid Glycoprotein Binding on Pharmacokinetics and Pharmacodynamics
Huang, Z., & Ung, T. (2013) · Current Drug Metabolism · doi:10.2174/138920013804870709 · Cited by 109
Garlic for hypertension: A systematic review and meta-analysis of randomized controlled trials
Xiong, X., Wang, P. Q., Li, S. J., Li, X. K., Zhang, Y. Q., & Wang, J. (2015) · Phytomedicine · doi:10.1016/j.phymed.2014.12.013 · Cited by 108
The dynamic gastric environment and its impact on drug and formulation behaviour
Abeele, J. V. D., Rubbens, J., Brouwers, J., & Augustijns, P. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.08.060 · Cited by 107
Self-citationKelly, K., O’Mahony, B., Lindsay, B., Jones, T., Grattan, T. J., Rostami‐Hodjegan, A., Stevens, H. N. E., & WILSON, C. G. (2003) · Pharmaceutical Research · doi:10.1023/a:1026155822121 · Cited by 105
Tapaninen, T., Neuvonen, P. J., & Niemi, M. (2010) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.101 · Cited by 104
Debersac, P., Vernevaut, M. F., Amiot, M. J., Suschetet, M., & Siess, M. H. (2001) · Food and Chemical Toxicology · doi:10.1016/s0278-6915(00)00117-4 · Cited by 103
Grimm, M. F., Scholz, E., Koziolek, M., Kühn, J., & Weitschies, W. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00623 · Cited by 103
Self-citationLennernäs, H., Ahrenstedt, Ö., & Ungell, A. ‐. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04309.x · Cited by 101
McCloy, R. F., Greenberg, G. R., & Baron, J. H. (1984) · Gut · doi:10.1136/gut.25.4.386 · Cited by 101
Meal-Induced Acceleration of Tablet Transit Through the Human Small Intestine
Fadda, H. M., McConnell, E. L., Short, M. B., & Basit, A. W. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9749-2 · Cited by 99
Self-citationShirasaka, Y., Shichiri, M., Mori, T., Nakanishi, T., & Tamai, I. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23653 · Cited by 99
Age-mediated changes in the gastrointestinal tract
Merchant, H. A., Liu, F., Orlu, M., & Basit, A. W. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.04.024 · Cited by 99
Self-citationMatušková, Z., Anzenbacherová, E., Večeřa, R., Tlaskalová‐Hogenová, H., Kolář, M., & Anzenbacher, P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087150 · Cited by 97
The Value Meal: How to Save $1,700 Per Month or More on Lapatinib
Ratain, M. J., & Cohen, E. E. W. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.0758 · Cited by 96
An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis)
Albassam, A. A., & Markowitz, J. C. (2017) · Planta Medica · doi:10.1055/s-0043-100934 · Cited by 96
Lee, S. H., Kim, H. Y., Back, S. Y., & Han, H. (2017) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1418854 · Cited by 95
Paracellular drug transport across intestinal epithelia: influence of charge and induced water flux
Karlsson, J. E., Ungell, A.-L. B., Gråsjö, J., & Artursson, P. (1999) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(99)00041-x · Cited by 94
Non-invasive quantification of small bowel water content by MRI: a validation study
Hoad, C. L., Marciani, L., Foley, S., Totman, J. J., Wright, J. W., Bush, D., Cox, E. F., Campbell, E., Spiller, R. E., & Gowland, P. A. (2007) · Physics in Medicine and Biology · doi:10.1088/0031-9155/52/23/009 · Cited by 93
Self-citationMarciani, L., Pritchard, S. E., Hellier-Woods, C., Costigan, C. M., Hoad, C. L., Gowland, P. A., & Spiller, R. E. (2013) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2013.78 · Cited by 93
Self-citationGershkovich, P., & Hoffman, A. (2007) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2007.05.109 · Cited by 92
Pharmacokinetics of Amiodarone in hyperlipidemic and simulated high fat‐meal rat models
Shayeganpour, A., Jun, A. S., & Brocks, D. R. (2005) · Biopharmaceutics & Drug Disposition · doi:10.1002/bdd.457 · Cited by 91
Influence of food on the absorption of acetylsalicylic acid from enteric-coated dosage forms
Bogentoft, C. B., Carlsson, I., Ekenved, G., & Magnusson, A. (1978) · European Journal of Clinical Pharmacology · doi:10.1007/bf00611905 · Cited by 90
Clinically Significant Drug Interactions with Antacids
Ogawa, R., & Echizen, H. (2011) · Drugs · doi:10.2165/11593990-000000000-00000 · Cited by 88
Pierro, F. D., Villanova, Agostini, F., Soverini, V., Marchesini, G., & Marzocchi (2012) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s33718 · Cited by 87
Jain, A. K., Söderlind, E., Viridén, A., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.058 · Cited by 86
Litou, C., Vertzoni, M., Goumas, C., Vasdekis, V., Xu, W., Kesisoglou, F., & Reppas, C. I. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1882-8 · Cited by 85
Self-citationEthanol Effects on Apparent Solubility of Poorly Soluble Drugs in Simulated Intestinal Fluid
Fagerberg, J. H., Al-Tikriti, Y., Ragnarsson, G., & Bergström, C. A. S. (2012) · Molecular Pharmaceutics · doi:10.1021/mp2006467 · Cited by 84
Fritz, A., Busch, D., Łapczuk-Romańska, J., Ostrowski, M., Droździk, M., & Oswald, S. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13137 · Cited by 82
The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential
van Zanden, J. J., van der Woude, H., Vaessen, J., Usta, M., Wortelboer, H. M., Cnubben, N. H. P., & Rietjens, I. M. C. M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.04.002 · Cited by 81
Enright, E. F., Joyce, S. A., Gahan, C. G. M., & Griffin, B. T. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b01155 · Cited by 81
Grimm, M. F., Koziolek, M., Saleh, M., Schneider, F., Garbacz, G., Kühn, J., & Weitschies, W. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.7b00919 · Cited by 81
Self-citationImpact of gut microbiota on drug metabolism: an update for safe and effective use of drugs
Noh, K., Kang, Y.-R., Nepal, M. R., Shakya, R., Kang, M. J., Kang, W., Lee, S., Jeong, H. G., & Jeong, T. C. (2017) · Archives of Pharmacal Research · doi:10.1007/s12272-017-0986-y · Cited by 80
Metabolism of Dietary Polyphenols and Possible Interactions with Drugs
Lambert, J. D., Sang, S., Lu, A. Y. H., & Yang, C. S. (2007) · Current Drug Metabolism · doi:10.2174/138920007780866870 · Cited by 79
The Monoamine Oxidase Inhibitor—Tyramine Interaction
Brown, C., Taniguchi, G., & Yip, K. (1989) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1989.tb03376.x · Cited by 79
Kang, S. P., & Ratain, M. J. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0663 · Cited by 79
Famurewa, A. C., Ufebe, O. G., Egedigwe, C. A., Nwankwo, O. E., & Obaje, S. G. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2016.12.123 · Cited by 79
Clinical relevance of drug binding to plasma proteins
Ascenzi, P., Fanali, G., Fasano, M., Pallottini, V., & Trezza, V. (2013) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2013.09.053 · Cited by 78
Interaction of Drug or Food with Drug Transporters in Intestine and Liver
Nakanishi, T., & Tamai, I. (2015) · Current Drug Metabolism · doi:10.2174/138920021609151201113537 · Cited by 76
Novel MRI tests of orocecal transit time and whole gut transit time: studies in normal subjects
Chaddock, G., Lam, C., Hoad, C. L., Costigan, C. M., Cox, E. F., Placidi, E., Thexton, I., Wright, J. W., Blackshaw, P. E., Perkins, A. C., et al. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12249 · Cited by 75
Self-citationCvijić, S., Parojčić, J., & Langguth, P. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.04.008 · Cited by 75
Kaminskas, L. M., Ascher, D. B., McLeod, V. M., Herold, M. J., Le, C. P., Sloan, E. K., & Porter, C. J. H. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.03.006 · Cited by 73
Self-citationReppas, C. I., Karatza, E., Goumas, C., Markopoulos, C., & Vertzoni, M. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1710-6 · Cited by 72
Self-citationVertzoni, M., Markopoulos, C., Symillides, M., et al. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200479f · Cited by 71
Self-citationEffects of soy containing diet and isoflavones on cytochrome P450 enzyme expression and activity
Ronis, M. J. J. (2016) · Drug Metabolism Reviews · doi:10.1080/03602532.2016.1206562 · Cited by 71
Cited by
The Bioavailability of Drugs—The Current State of Knowledge
Stielow, M., Witczyńska, A., Kubryń, N., Fijałkowski, Ł., Nowaczyk, J., & Nowaczyk, A. (2023) · Molecules · doi:10.3390/molecules28248038 · Cited by 391
Vinarov, Z., Abdallah, M., Agundez, J. A. G., Allegaert, K., Basit, A. W., Braeckmans, M., Ceulemans, J., Corsetti, M., Griffin, B. T., Grimm, M., et al. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105812 · Cited by 359
Self-citationRe-thinking functional food development through a holistic approach
Alongi, M., & Anese, M. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104466 · Cited by 278
Bender, A., & Cortes-Ciriano, I. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.11.037 · Cited by 232
Let’s talk about sex: Differences in drug therapy in males and females
Madla, C. M., Gavins, F. K. H., Merchant, H. A., Orlu, M., Murdan, S., & Basit, A. W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.014 · Cited by 167
Self-citation
Metadata
- Authors
- Koziolek, M., Alcaro, S., Augustijns, P., Basit, A. W., Grimm, M., Hens, B., Hoad, C. L., Jedamzik, P., Madla, C. M., Maliepaard, M., Marciani, L., Maruca, A., Parrott, N., Pávek, P., Porter, C. J. H., Reppas, C., van Riet-Nales, D., Rubbens, J., Statelova, M., Trevaskis, N. L., Valentová, K., Vertzoni, M., Čepo, D. V., & Corsetti, M.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2019-06
- Volume
- 134
- Pages
- 31-59
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2937963363
- Cited by
- 385
- References
- 274
- FWCI
- 40.83
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.